… SARS-CoV-2-induced coronavirus disease-19 (COVID-19) has become one of the main …
immunological data on mechanisms associated with the SARS-CoV-2 infection and COVID-19 …

… frequent comorbidity among patients with COVID-19, 32 to date, asthma has not been
robustly considered a significant risk factor for developing severe COVID-19, 33 increased risk of …

… We will present clinical and immunological aspects that have to be considered with
regard to the COVID-19 pandemic in patients treated with biological therapy against IgE and …

… coronavirus 2 (SARS-CoV-2), was identified as the cause of the Coronavirus disease 2019
(COVID-19) … The European Academy of Allergy and Clinical Immunology (EAACI), but also …

… of an infectious disease defined as “Coronavirus disease 2019 (COVID-19)”. The COVID-19
pandemic is currently spreading around the globe. COVID-19 is caused by a novel strain of …

… to COVID-19 vaccination. Four SARS-CoV-2 vaccines are currently approved in the EU, and
their possible immunological … recommend an interval of ~ 1 week to COVID-19 vaccination. …

… approval of the Coronavirus disease 2019 (COVID-19) vaccine … , the European Academy
of Allergy and Clinical Immunology (… immunity. Healthcare practitioners vaccinating against …

… Consistent with the development of immunity after COVID-19 infection, a recent study of
SARS-CoV-2 infection in rhesus macaques found that two macaques that had resolved the …

… , which may partly contribute to COVID-19-associated damage. … in patients with severe
COVID-19 seemed to positively impact … In summary, severely affected COVID-19 patients exhibit …

… , 14 preventive measures, 10, 11, 15 and Position Statements elaborated by experts in the
field in close collaboration with the European Academy of Allergy and Clinical Immunology (…